| (Values in U.S. Thousands) | Jun, 2025 | Mar, 2025 | Sep, 2024 | Jun, 2024 | Mar, 2024 |
| Sales | 29 | 434 | 1,421 | 1,195 | 1,045 |
| Sales Growth | -93.39% | -69.46% | +18.91% | +14.34% | -7.04% |
| Net Income | -459 | -77 | -713 | -179 | 54 |
| Net Income Growth | -493.32% | +89.14% | -298.02% | -431.37% | -67.95% |
Avricore Health Inc (AVCR.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and the sale of testing panels.
Fiscal Year End Date: 12/31